Drugs / H-Bupivacaine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02387060 Background | Aug 2014 → Dec 2015 | — | Pontificia Universidad Catolica de Chile | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H-Bupivacaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02387060 ↗ |
| Route | Intrathecal | “Intrathecal administration of hyperbaric bupivacaine 1.5 ml 0.75%” NCT02387060 ↗ |